PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 30, 2020Arteriosclerosis Thrombosis and Vascular Biology211 citationsOpen Access

Evidence-Based Medical Management of Peripheral Artery Disease

View Full Paper
GBGraham H. BevanKSKhendi White Solaru

Structured PICO

P
Population
Patients with peripheral artery disease
I
Intervention
Medical therapies including cholesterol reduction, antiplatelet therapy, anticoagulation, peripheral vasodilators, blood pressure management, exercise therapy, and smoking cessation

This review highlights the multifaceted medical approach to peripheral artery disease, emphasizing its role in reducing limb-related and systemic complications.

Abstract

Peripheral artery disease is an atherosclerotic disease of the lower extremities associated with high cardiovascular mortality. Management of this condition may include lifestyle modifications, medical management, endovascular repair, or surgery. The medical approach to peripheral artery disease is multifaceted and includes cholesterol reduction, antiplatelet therapy, anticoagulation, peripheral vasodilators, blood pressure management, exercise therapy, and smoking cessation. Adherence to this regimen can reduce limb-related complications like critical limb ischemia and amputation, as well as systemic complications of atherosclerosis like stroke and myocardial infarction. Relative to coronary artery disease, peripheral artery disease is an undertreated condition. In this article, we explore the evidence behind medical therapies for the management of peripheral artery disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bevan et al. (2020) studied this question.

synapsesocial.com/papers/69d6bce6a0177bf533ed8bfbhttps://doi.org/10.1161/atvbaha.119.312142
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia2018 · 3,315 citations
  2. 2Smoking Cessation Is the Least Successful Outcome of Risk Factor Modification in Uninsured Patients with Symptomatic Peripheral Arterial Disease2014 · 20 citations
  3. 3Functional Decline in Peripheral Arterial Disease2004 · 647 citations
  4. 4Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease2016 · 634 citations
  5. 5Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease2017 · 764 citations